FOXM1 and ovarian cancer: To investigate the expression of FOXM1 in cisplatin sensitive or resistant ovarian cancer, ovarian cancer tissue samples were obtained from 10 women with recurrent epithelial ovarian cancer in 6 months after standard therapy, and other 10 women who were chemosensitive.